Semaglutide le Tirzepatide ke meriana e 'meli e mecha e thehiloeng ho GLP-1 e sebelisetsoang ho phekola lefu la tsoekere la mofuta oa 2 le botenya.
Semaglutide e bontšitse liphello tse phahameng ho fokotsa maemo a HbA1c le ho khothalletsa ho lahleheloa ke boima ba 'mele. Tirzepatide, e leng novel dual GIP/GLP-1 receptor agonist, e boetse e amohetsoe ke US FDA le European EMA bakeng sa kalafo ea lefu la tsoekere la mofuta oa 2.
Katleho
Semaglutide le tirzepatide li ka fokotsa haholo maemo a HbA1c ho bakuli ba nang le lefu la tsoekere la mofuta oa 2, kahoo ba ntlafatsa taolo ea tsoekere ea mali.
Mabapi le ho lahleheloa ke boima ba 'mele, tirzepatide ka kakaretso e bontša liphello tse molemo ha li bapisoa le semaglutide.
Kotsi ea pelo
Semaglutide e bontšitse melemo ea pelo ea pelo tekong ea SUSTAIN-6, ho kenyelletsa le likotsi tse fokotsehileng tsa lefu la pelo, lefu le sa bolaeang la myocardial infarction, le stroke e sa bolaeang.
Litlamorao tsa pelo ea Tirzepatide li hloka boithuto bo eketsehileng, haholo liphetho tse tsoang tekong ea SURPASS-CVOT.
Litumello tsa Lithethefatsi
Semaglutide e amohetsoe e le tlatsetso ea lijo le boikoetliso ho ntlafatsa taolo ea tsoekere ea mali ho batho ba baholo ba nang le lefu la tsoekere la mofuta oa 2, le ho fokotsa kotsi ea liketsahalo tse kholo tsa pelo ho batho ba baholo ba nang le lefu la tsoekere la mofuta oa 2 le ho theha lefu la pelo.
Tirzepatide e amohetsoe e le tlatsetso ea lijo tse fokotsehileng tsa khalori le boikoetliso bo eketsehileng ba 'mele bakeng sa taolo ea boima bo sa foleng ho batho ba baholo ba nang le botenya kapa boima bo feteletseng le bonyane bo bong bo amanang le boima ba' mele.
Tsamaiso
Ka bobeli semaglutide le tirzepatide hangata li tsamaisoa ka ente ea subcutaneous.
Semaglutide e boetse e na le tlhahiso ea molomo e fumanehang.
Nako ea poso: Jul-08-2025